Merck & Co., Inc.
MRKNYSECIK 310158HealthcareFiscal year ends Dec 31
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2906:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-119825 |
| 2026-10-1312:36 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000310158-26-000237 |
| 2026-08-0716:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000310158-26-000212 |
| 2026-08-0406:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-090045 |
| 2026-05-2816:15 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-067509 |
| 2026-05-2216:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-037738 |
| 2026-05-0416:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-029802 |
| 2026-04-3006:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-052081 |
| 2026-04-0816:25 ET | DEF 14A | Proxy statementPeriod 2026-05-26 | 0001193125-26-147704 |
| 2026-02-2416:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000310158-26-000063 |
| 2026-02-0306:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-009495 |
| 2025-12-0416:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-055388 |
| 2025-11-0516:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000310158-25-000059 |
| 2025-10-3006:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-103974 |
| 2025-09-0916:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000310158-25-000047 |
| 2025-08-0516:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000310158-25-000014 |
| 2025-07-2906:42 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001104659-25-071380 |
| 2025-05-2913:46 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-054131 |
| 2025-05-0216:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-021834 |
| 2025-04-2406:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-038301 |
| 2025-04-0916:16 ET | DEF 14A | Proxy statementPeriod 2025-05-27 | 0001193125-25-076859 |
| 2025-02-2516:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-007732 |
| 2025-02-0406:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-008863 |
| 2024-11-2214:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-122027 |
| 2024-11-0616:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045689 |
| 2024-10-3106:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-112841 |
| 2024-08-0516:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-034715 |
| 2024-07-3006:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-083722 |
| 2024-05-3016:14 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-025800 |
| 2024-05-0316:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-020283 |
| 2024-04-2506:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-051517 |
| 2024-04-1116:08 ET | DEF 14A | Proxy statementPeriod 2024-05-28 | 0001193125-24-093204 |
| 2024-04-1116:05 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001193125-24-093194 |
| 2024-02-2616:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-006850 |
| 2024-02-2016:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-025524 |
| 2024-02-0106:39 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001104659-24-009109 |
| 2023-11-2816:51 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-121671 |
| 2023-11-0316:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-036717 |
| 2023-10-2606:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-111585 |
| 2023-08-0716:09 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-027770 |
| 2023-08-0106:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-086030 |
| 2023-05-2609:00 ET | 8-K | 5.07 Shareholder vote results | 0001140361-23-026845 |
| 2023-05-1716:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-147049 |
| 2023-05-0507:39 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001628280-23-015990 |
| 2023-04-2706:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-050654 |
| 2023-04-0316:06 ET | DEF 14A | Proxy statement | 0001193125-23-089525 |
| 2023-02-2416:22 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001628280-23-005061 |
| 2023-02-0206:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-009552 |
| 2022-11-0316:28 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000310158-22-000034 |
| 2022-10-2706:38 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-111729 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 06:44 ET. Listed shows no prices and gives no investment advice.